Last updated on February 2018

Effectiveness of Aurix Therapy in Venous Leg Ulcers


Brief description of study

The aim of this trial is to demonstrate the effectiveness of complete wound healing in a prospective, open-label, randomized trial in which venous leg ulcers (VLU)n will be treated using Aurix and compared to patients receiving undefined Usual and Customary Care (UCC)

Detailed Study Description

Recurrence of ulcers in the leg is common; two-thirds of patients are likely to experience recurring ulcers after the first ulcer. While treatment of the underlying venous disease, depending on the mode of treatment, can lower the recurrence rate in many patients, it does not affect recurrence. Aurix is a platelet-rich plasma (PRP) gel used in the treatment of non-healing chronic wounds. The aim of this trial is to demonstrate the effectiveness, measured as complete wound healing, in a prospective, randomized trial in which venous leg ulcers will be treated using Aurix and standard of care and compared 1:1 to patients receiving undefined Usual and Customary Care (UCC).

Clinical Study Identifier: NCT02352454

Find a site near you

Start Over

Arizona Heart

Phoenix, AZ United States
  Connect »

Western Maryland

Cumberland, MD United States
  Connect »

Piedmont

Atlanta, GA United States
  Connect »

Orange Regional

Middletown, NY United States
  Connect »

The Wound Center of Niagara

Niagara Falls, NY United States
  Connect »

Berger Wound Healing Center

Circleville, OH United States
  Connect »

Aria Health Bucks Wound Center

Langhorne, PA United States
  Connect »